Plasticity of Glutamate and GABAA Receptors in the Hippocampus of Patients with Alzheimer's Disease

Abstract1. Aim: In Alzheimer's disease (AD) it is well known that specific regions of the brain are particularly vulnerable to the pathologic insults of the disease. In particular, the hippocampus is affected very early in the disease and by end stage AD is ravaged by neurofibrillary tangles and senile plaques (i.e., the pathologic hallmarks of AD). Throughout the past several years our laboratory has sought to determine the molecular mechanisms underlying the selective vulnerability of neurons in AD.2. Methods: To this end, we employed immunohistochemical, biochemical, and in situ hybrization methods to examine glutamate and γ-aminobutyric acid (GABAA) receptor subtypes in the hippocampus of patients displaying the full spectrum of AD pathology.3. Results: Despite the fact that the hippocampus is characterized by a marked loss of neurons in the late stages of the disease, our data demonstrate a rather remarkable preservation among some glutamate and GABAA receptor subtypes.4. Conclusions: Collectively, our data support the view that the relatively constant levels of selected receptor subtypes represent a compensatory up-regulation of these receptors subunits in surviving neurons. The demonstration that glutamate and GABA receptor subunits are comparably unaffected implies that even in the terminal stages of the disease the brain is “attempting” to maintain a balance in excitatory and inhibitory tone. Our data also support the concept that receptor subunits are differentially affected in AD with some subunits displaying no change while others display alterations in protein and mRNA levels within selected regions of the hippocampus. Although many of these changes are modest, they do suggest that the subunit composition of these receptors may be altered and hence affect the pharmacokinetic and physiological properties of the receptor. The latter findings stress the importance of understanding the subunit composition of individual glutamate/GABA receptors in the diseased brain prior to the development of drugs targeted towards those receptors.

[1]  Deborah Dewar,et al.  Rat and Human Hippocampal α5 Subunit-Containing γ-Aminobutyric AcidA Receptors Have α5β3γ2 Pharmacological Characteristics , 1998 .

[2]  D. Armstrong,et al.  AMPA-Selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer disease , 1996, Molecular and chemical neuropathology.

[3]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[4]  D. Armstrong,et al.  GABAA receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology , 1998 .

[5]  R. Mckernan,et al.  Structure and pharmacology of vertebrate GABAA receptor subtypes. , 1995, International review of neurobiology.

[6]  R. Rubin,et al.  Immunohistochemical Study of GABAAReceptor β2/3 Subunits in the Hippocampal Formation of Aged Brains with Alzheimer-Related Neuropathologic Changes , 1997, Experimental Neurology.

[7]  R. Olsen,et al.  Molecular biology of GABAA receptors , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Rissman,et al.  Biochemical analysis of GABAA receptor subunits α1, α5, β1, β2 in the hippocampus of patients with Alzheimer's disease neuropathology , 2003, Neuroscience.

[9]  P. Seeburg.  The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channels , 1993, Trends in Neurosciences.

[10]  R. Olsen,et al.  GABAA receptor channels. , 1994, Annual review of neuroscience.

[11]  D. Armstrong,et al.  Alterations of AMPA-selected glutamate subtype immunoreactivity in the dentate gyrus after perforant pathway lesion , 1997, Brain Research.

[12]  Katsuyoshi Mizukami,et al.  Immunohistochemical study of GABAA receptor α1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes , 1998, Brain Research.

[13]  J. Fritschy,et al.  GABAA‐receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits , 1995, The Journal of comparative neurology.

[14]  D. Armstrong,et al.  Glutamate Receptors in Aging and Alzheimer's Disease , 2001 .

[15]  D. Armstrong,et al.  AMPA‐selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation , 1995, The Journal of comparative neurology.

[16]  P. Davies,et al.  The Loss of GluR2(3) Immunoreactivity Precedes Neurofibrillary Tangle Formation in the Entorhinal Cortex and Hippocampus of Alzheimer Brains , 1997, Journal of neuropathology and experimental neurology.

[17]  J. Benson,et al.  The GABAA Receptors , 1996 .

[18]  G. V. Van Hoesen,et al.  Perforant pathway changes and the memory impairment of Alzheimer's disease , 1986, Annals of neurology.

[19]  R. Rissman,et al.  Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology , 2004, Neurobiology of Disease.

[20]  R. Mckernan,et al.  Molecular and Functional Diversity of the Expanding GABA‐A Receptor Gene Family , 1999, Annals of the New York Academy of Sciences.

[21]  V. Teichberg,et al.  A tetrameric subunit stoichiometry for a glutamate receptor–channel complex , 1998, Neuroreport.

[22]  D. Armstrong,et al.  AMPA‐selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease , 1995, Hippocampus.

[23]  J. Benson,et al.  The GABAA receptors. From subunits to diverse functions. , 1996, Ion channels.

[24]  Bert Sakmann,et al.  Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes , 1992, Science.

[25]  R. Wenthold,et al.  Distribution of Glutamate Receptor Subunit NMDAR1 in the Hippocampus of Normal Elderly and Patients with Alzheimer's Disease , 1999, Experimental Neurology.

[26]  R. Wenthold,et al.  AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease , 1994, Brain Research.

[27]  K. Moriyoshi,et al.  Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. , 1993, The Journal of biological chemistry.

[28]  S. Heinemann,et al.  Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition , 1991, Science.

[29]  S. Vicini,et al.  Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. , 1998, Journal of neurophysiology.